knowledge -WSS

knowledge

author：explore 2025-09-30 20:35:42 - browse：16

Microsoft's head of research Peter Lee speaking at STAT Breakthrough Summit in San Francisco. Sarah Gonzalez for STAT

SAN FRANCISCO — Surging interest in generative AI among medical professionals since ChatGPT’s launch is perhaps a testament to its potential — but it could also lead clinicians, and patients to experiment with it before there is wider consensus on how to navigate its biases and other pitfalls, Microsoft’s head of research Peter Lee said Thursday at STAT’s Breakthrough Summit.

About a month after OpenAI — Microsoft has a significant financial stake in the company — launched its chatbot in 2022 on November 30, which happened to be Lee’s birthday, he got a note from a doctor friend who said he’d used it so his receptionist could file after-visit summaries for patients. While Lee and a handful of other doctors at Microsoft had been impressed with the GPT-4’s capabilities, they knew it had weaknesses.

“The emotions were really mixed. I mean we were thrilled,” he said, but then “just within minutes there’s a feeling of dread. We had already come to the realization that GPT-4 would be prone to issues, issues of bias, hallucination, mathematical and logical errors,” he said. “And so, there’s an immediate question: ‘Should we allow this to happen?’”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Apple is now the first public company to be valued at $3 trillion

knowledge

WSS

Healthy food access boosts outcomes in two studies

After affirmative action ruling, medical educators look to 'holistic review'

23andMe had bad news about my health. I wish a person had delivered it

Medical school prerequisites are outdated

Experimental asthma app from Apple and Anthem shows promise

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

entertainment

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

focus

At least 13 dead in Texas as scorching temps continue

Dobbs anniversary: the lost opportunity of abortion as health care

Apple is now the first public company to be valued at $3 trillion

Walensky prepares to leave CDC — and Congress — behind

United colonoscopy coverage change 'may cost lives,' doctors say

Publishing genetic code of viruses could cause disaster

Trump demands the U.S. pay no more for drugs than other countries … again

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

DIEP, the 'gold standard' of breast reconstruction, is under threat

focus

NIH chief: government has fallen behind pharma on clinical trials

Bright Health sells Medicare Advantage business to Molina

Ohio still needs to do more to protect the right to abortion

Medicare’s new pay boost for primary care is angering specialists

United colonoscopy coverage change 'may cost lives,' doctors say

FDA reorg will put new emphasis on investigations, sources say

Wikipedia

knowledge

Wikipedia

leisure time